Summary

SANTA™ platform offers a novel approach to therapy by utilizing off-label cytostatic drugs with low toxicity.

Through this platform mitochondrial reforming and apoptosis inducing new chemical entity (NCE) are formed by cytostatic off-label drug complexes with ionic or covalent bonds. This allows multiple drugs to be taken up into a single cancer cell simultaneously, exhibiting synergistic effects and minimizing harm to normal cells.

The self-assembled nano formulation enhances bioavailability to improve its’ efficacy for cancer, tumor dormancy, cancer cachexia, muscle and fat metabolic diseases.